Internal Medicine, Nephrology · Phoenix, AZ
NPI
1457658007
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
9250 N 3rd St Ste 3015
Phoenix, AZ, 85020
Phone (601) 780-2780
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
1,776 services
Medicare patients, 2024
331
Average age 74
Drug cost, 2024
$288K
553 prescriptions
Company payments, 2025
$262
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sohail Abdul Salim was code 99233 (hospital e&m - subsequent), 569 times for 168 patients. In total Sohail Abdul Salim billed 1,776 services in 32 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 569 | 168 | $87.91 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 447 | 189 | $58.95 | $26K |
| 99223 Hospital E&M - Initial | Facility | 200 | 173 | $129.53 | $26K |
| 99291 Critical Care E&M | Facility | 51 | 11 | $161.70 | $8,247 |
| 99215 Office E&M - Established | Office | 29 | 25 | $121.92 | $3,536 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $99.70 | $2,592 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 23 | 20 | $12.57 | $289 |
| 99205 Office E&M - New | Office | 19 | 19 | $148.18 | $2,815 |
| 80069 Clinical Chemistry | Office | 19 | 17 | $8.51 | $162 |
By year: 2022 $121K for 1,802 services; 2023 $149K for 1,910 services; 2024 $143K for 1,776 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80069 Clinical Chemistry | 19 | 17 | $8.51 | $162 |
Medicare prescription drug claims, 2024
In 2024, the drug Sohail Abdul Salim prescribed most often to Medicare patients was Lokelma (Sodium Zirconium Cyclosilicate), with 64 prescriptions and refills. In total Sohail Abdul Salim wrote 553 Medicare prescriptions that cost $288K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lokelma Sodium Zirconium Cyclosilicate | 64 | 72 | 18 | $35K |
| Fosrenol Lanthanum Carbonate | 37 | 37 | Under 11 | $19K |
| Losartan Potassium Generic | 36 | 87 | 13 | $281 |
| Epogen Epoetin Alfa | 35 | 35 | Under 11 | $53K |
| Farxiga Dapagliflozin Propanediol | 35 | 37 | Under 11 | $20K |
| Sevelamer Carbonate Generic | 28 | 34 | Under 11 | $17K |
| Furosemide Generic | 27 | 52 | 16 | $186 |
| Retacrit Epoetin Alfa-Epbx | 24 | 24 | Under 11 | $18K |
| Procrit Epoetin Alfa | 23 | 23 | Under 11 | $54K |
| Doxercalciferol Generic | 22 | 22 | Under 11 | $347 |
| Albuked-25 Albumin Human | 20 | 20 | Under 11 | $27K |
| Nifedipine Er Nifedipine | 18 | 38 | Under 11 | $182 |
| Calcium Acetate Generic | 16 | 16 | Under 11 | $1,514 |
| Lisinopril Generic | 14 | 42 | Under 11 | $105 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $496 |
Brand drugs: 281 claims; generic drugs: 272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sohail Abdul Salim $262 ($262 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $134.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $134 |
| Vantive US Healthcare LLC | 1 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.